Inhibitory effects of different galanin compounds and fragments on osmotically and histamine-induced enhanced vasopressin secretion in rats.
The effects of rat, porcine and human galanin, and the human 1-16 and human 16-30 terminal galanin fragments on vasopressin secretion were studied in rat. The plasma vasopressin level was determined by radioimmunoassay (RIA). There were no changes in the basal vasopressin secretion after galanin administration. A significant increase in vasopressin concentration was detected following 2.5% NaCl or histamine administration. I.c.v. injected rat, porcine or human galanin or the 1-16 N-terminal galanin fragment prevented the plasma vasopressin level enhancement. Following the i.v. administration of rat galanin or the i.c.v. injected 16-30 C-terminal galanin fragment, the vasopressin concentration did not return to the normal level. Administration of the galanin antagonist galantid (M15) i.c.v. before the rat galanin i.c.v. injection prevented the inhibitory effect on the increased plasma vasopressin level following 2.5% NaCl solution or histamine administration. The results indicate that there is no significant difference in the inhibitory effect of rat, porcine or human galanin or the 1-16 galanin fragment on the enhanced plasma vasopressin secretion induced by hyperosmosis or histamine administration. Our findings suggest that galanin, as a peptide modulator, is physiologically involved in the regulation of vasopressin release following different forms of stimulation: an osmotic response or histamine administration.
Molnár
Andor
A
Department of Comparative Physiology, University of Szeged, Középfasor 52., H-6726 Szeged, Hungary.
Baláspiri
Lajos
L
Gálfi
Márta
M
László
Ferenc
F
Varga
Csaba
C
Berkó
Anikó
A
László
Ferenc A
FA
D000818:Animals; D019004:Galanin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*; D006632:Histamine / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D008297:Male; D009997:Osmotic Pressure; D010446:Peptide Fragments / Q000008:administration & dosage / Q000494:pharmacology; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D013373:Substance P / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D013552:Swine; D014667:Vasopressins / Q000097:blood / Q000378:metabolism*
D010446:Peptide Fragments; D014667:Vasopressins; C074975:galantide; D013373:Substance P; D006632:Histamine; D019004:Galanin